AI
ACLS icon

Atria Investments’s Axcelis ACLS Stock Holding History

Atria Investments’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$364K Buy
+3,906
New +$346K ﹤0.01% 1630

Other funds holding ACLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Atria Investments's ACLS Position: Q1 2026 in Review

Atria Investments opened a new position in Axcelis (ACLS) in Q1 2026: 3,906 shares worth $364K. The stake represents ﹤0.01% of the portfolio and ranks #1630 among its holdings.

377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Atria Investments held 3,906 shares of Axcelis worth $364K as of Q1 2026.
  • Axcelis was a new Atria Investments position in Q1 2026.
  • Axcelis made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1630 holding.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.